Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pandey

Showing results (761-770 of 778) with videos related to

Pageof 78
Sort By:
Science Translational Medicine|December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infectionRebecca M Lynch, Eli Boritz, Emily E Coates, et al.
The Lancet. HIV|September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trialMartin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
JCI Insight|February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infectionMyra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
JCI Insight|April 8, 2024
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LSSeemal F Awan, Amarendra Pegu, Larisa Strom, et al.
Cell|July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacyCatherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Physical Review Letters|January 21, 2022
Improved Λp Elastic Scattering Cross Sections between 0.9 and 2.0  GeV/c as a Main Ingredient of the Neutron Star Equation of StateJ Rowley, N Compton, C Djalali, et al.
Computers in Biology and Medicine|April 28, 2022
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveysPrateek Singh, Rajat Ujjainiya, Satyartha Prakash, et al.
Physical Review Letters|July 28, 2023
First Measurement of Hard Exclusive π^{-}Δ^{++} Electroproduction Beam-Spin Asymmetries off the ProtonS Diehl, N Trotta, K Joo, et al.
Physical Review Letters|November 14, 2022
Observation of Azimuth-Dependent Suppression of Hadron Pairs in Electron Scattering off NucleiS J Paul, S Morán, M Arratia, et al.
Pageof 78

Showing results (761-770 of 778) with videos related to

Sort By:
Pageof 78
Science Translational Medicine|December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infectionRebecca M Lynch, Eli Boritz, Emily E Coates, et al.
The Lancet. HIV|September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trialMartin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
JCI Insight|February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infectionMyra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
JCI Insight|April 8, 2024
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LSSeemal F Awan, Amarendra Pegu, Larisa Strom, et al.
Cell|July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacyCatherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Physical Review Letters|January 21, 2022
Improved Λp Elastic Scattering Cross Sections between 0.9 and 2.0  GeV/c as a Main Ingredient of the Neutron Star Equation of StateJ Rowley, N Compton, C Djalali, et al.
Computers in Biology and Medicine|April 28, 2022
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveysPrateek Singh, Rajat Ujjainiya, Satyartha Prakash, et al.
Physical Review Letters|July 28, 2023
First Measurement of Hard Exclusive π^{-}Δ^{++} Electroproduction Beam-Spin Asymmetries off the ProtonS Diehl, N Trotta, K Joo, et al.
Physical Review Letters|November 14, 2022
Observation of Azimuth-Dependent Suppression of Hadron Pairs in Electron Scattering off NucleiS J Paul, S Morán, M Arratia, et al.
Pageof 78